Curcumin potentiates the antitumor effects of gemcitabine in an orthotopic model of human bladder cancer through suppression of proliferative and angiogenic biomarkers - Abstract
Wednesday, 02 September 2009
Department of Urology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, United States.
read more
|
BJUI Mini Reviews - Secondary neoplasms of the urinary system and male genital organs
Tuesday, 01 September 2009
This review provides a discussion of those secondary
tumours involving the urinary system
and male genital organs that can pose
differential diagnostic difficulties
with primary lesions, and highlights
morphological and ancillary features that
could be helpful in reaching a proper
assignment of primary origin.
Login to read more...
|
Hexyl aminolevulinate fluorescence cystoscopy in bladder cancer - Abstract
Tuesday, 01 September 2009
Department for Urology, University of Tuebingen, Germany.
read more
|
miR-200 expression regulates epithelial-to-mesenchymal transition in bladder cancer cells and reverses resistance to epidermal growth factor receptor therapy - Abstract
Tuesday, 01 September 2009
The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA.
read more
|
Conservative treatment of invasive bladder cancer - Abstract
Tuesday, 01 September 2009
Department of Radiation Oncology, McGill University Health Centre, Montreal, QC.
read more
|
Hexvix® has been granted priority review by the FDA
Monday, 31 August 2009
OSLO, NORWAY (Press Release) - August 31, 2009
read more
|
BJUI Mini Reviews - The role of lymphangiogenesis in lymphatic tumour spread of urological cancers
Monday, 31 August 2009
This article summarizes preliminary evidence on the role of lymphangiogenesis during the formation of lymphatic metastasis in the most common urological cancers.
Login to read more...
|
A 10-year retrospective review of a nonrandomized cohort of 458 patients undergoing radical radiotherapy or cystectomy in Yorkshire, UK - Abstract
Monday, 31 August 2009
Department of Urology, Mid Yorkshire NHS Trust, Pinderfields Hospital, Aberford Road, Wakefield.
read more
|
Identification, molecular characterization, clinical prognosis, and therapeutic targeting of human bladder tumor-initiating cells - Abstract
Monday, 31 August 2009
Institute for Stem Cell Biology and Regenerative Medicine, Stanford Cancer Center, Stanford University School of Medicine, Stanford, CA 94304-5542, USA.
read more
|
Early assessment for bladder cancer could improve early detection rates for women
Friday, 28 August 2009
BEDFORD, UK (Press Release) PRLog - August 28, 2009
read more
|
URS 2009 - Heme oxygenase-1 expression correlates with chemo-resistance against intravesical administration of anthracycline antitumor drugs in non-muscle invasive bladder cancer - Abstract
Friday, 28 August 2009
PORT DOUGLAS, AUSTRALIA (UroToday.com) - Heme oxygenase (HO) is a microsomal late-limiting enzyme in heme degradation. HO-1 is normally found at a faint expression level, but is upregulated for an adaptive response to various stress stimuli, such as oxidative stress, hypoxia, and hyperthermia.
Login to read more...
|
URS 2009 - Metabonomics in bladder cancer detection - Abstract
Friday, 28 August 2009
PORT DOUGLAS, AUSTRALIA (UroToday.com) - Cystoscopy is considered as the current gold standard for diagnosis of bladder carcinoma.
Login to read more...
|
URS 2009 - Prediction of response to intravesical BCG by genome-wide cDNA microarray analysis: In primary T1 bladder cancer - Abstract
Friday, 28 August 2009
PORT DOUGLAS, AUSTRALIA (UroToday.com) - While intravesical administration of bacillus Calmette–Guérin (BCG) following resection of non-muscle invasive bladder cancer (BC) is the current ‘gold standard’, many patients will fail to response.
Login to read more...
|
URS 2009 - Invasive TCC in the Elderly: Radical cystectomy? - Abstract
Friday, 28 August 2009
PORT DOUGLAS, AUSTRALIA (UroToday.com) - To reduce morbidity in the elderly patient, conservative multimodal therapy concepts for invasive bladder cancer are emerging as an alternative to radical cystectomy.
Login to read more...
|
Bladder tumor in women with microscopic hematuria: an Iranian experience and a review of the literature - Abstract
Friday, 28 August 2009
Dr. Taheri Medical Research Group, Baqiyatallah Research Center for Gastroenterology and Liver diseases, Baqiyatallah Hospital, Mullasadra Ave, Tehran 1435915371, Iran.
read more
|
Cytotoxic activity of gemcitabine in cultured cell lines derived from histologically different types of bladder cancer: Role of thymidine kinase 2 - Abstract
Thursday, 27 August 2009
Department of Oncology, University of Alberta and Cross Cancer Institute, Edmonton, Alberta, Canada T6G 1Z2.
read more
|
Diagnosis of bladder cancer with microelectromechanical systems-based cystoscopic optical coherence tomography - Abstract
Thursday, 27 August 2009
Department of Biomedical Engineering, SUNY at Stony Brook, Stony Brook, New York, USA.
read more
|
Beyond the Abstract - Office cystoscopy and transrectal ultrasound-guided prostate biopsies pose minimal risk: Prospective evaluation of 921 procedures, by Surena F. Matin, MD
Wednesday, 26 August 2009
BERKELEY, CA (UroToday.com) - The Institute of Medicine has drawn professional and public attention to the safety of patients in our health care system through two prominent publications.
Login to read more...
|
Increased cancer risk of augmentation cystoplasty: Possible role for hyperosmolal microenvironment on DNA damage recognition - Abstract
Wednesday, 26 August 2009
Division of Nephrology and Hypertension, Cincinnati Children's Hospital Medical Center, MLC 7022, 3333 Burnet Avenue, Cincinnati, OH 45229-3039, United States.
read more
|
Prospective study of [18F]fluorodeoxyglucose positron emission tomography/computed tomography for staging of muscle-invasive bladder carcinoma - Abstract
Wednesday, 26 August 2009
Divisions of Urologic Surgery, Nuclear Medicine, Anatomic and Molecular Pathology, Diagnostic Radiology, and Biostatistics; Departments of Surgery and Pathology and Immunology; Mallinckrodt Institute of Radiology; and Alvin J. Siteman Cancer Center, Washington University School of Medicine, St Louis, MO.
read more
|
Intravesical immunotherapy of superficial bladder cancer with chitosan/interleukin-12 - Abstract
Tuesday, 25 August 2009
Laboratory of Tumor Immunology Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland 20892, USA.
read more
|
Effect of vascular endothelial growth factor and its receptor inhibitor on proliferation and invasion in bladder cancer - Abstract
Tuesday, 25 August 2009
Department of Urology, Institute of Health Biosciences, University of Tokushima Graduate School, Tokushima, Japan.
read more
|
Maratona Urológica 2009 - Scientific Program
Tuesday, 25 August 2009
Login to read more...
|
Consistent genomic alterations in carcinoma in situ of the urinary bladder confirm the presence of two major pathways in bladder cancer development - Abstract
Monday, 24 August 2009
Department of Molecular Medicine, Arhus University Hospital, Skejby, Denmark.
read more
|
Prognostic significance of neuron-associated protein expression in non-muscle-invasive urothelial bladder cancer - Abstract
Monday, 24 August 2009
Department of Pathology and Laboratory Medicine at Roswell Park Cancer Institute, Elm and Carlton Street, Buffalo, NY 14263, USA.
read more
|
Secondary neoplasms of the urinary system and male genital organs - Abstract
Friday, 21 August 2009
Department of Pathology, Reina Sofia University Hospital and Faculty of Medicine, Cordoba, Spain.
read more
|
Late pelvic toxicity after bladder-sparing therapy in patients with invasive bladder cancer: RTOG 89-03, 95-06, 97-06, 99-06 - Abstract
Friday, 21 August 2009
Departments of Radiation Oncology and Urology, and the Division of Hematology and Oncology, Massachusetts General Hospital, Boston MA.
read more
|
Meta-analysis of fluorescence in situ hybridization and cytology for diagnosis of bladder cancer - Abstract
Friday, 21 August 2009
Department of Urology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, 410011, P. R. China.
read more
|
Acute and late toxicity in radical radiotherapy for bladder cancer - Abstract
Thursday, 20 August 2009
To evaluate the incidence, severity and kinetics of acute and late toxicity from bladder and bowels in patients with bladder cancer treated with radical radiotherapy.
read more
|
Clinical outcome in a contemporary series of restaged patients with clinical T1 bladder cancer - Abstract
Wednesday, 19 August 2009
Division of Urology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
read more
|
Maratona Urológica 2009 - Management of muscle invasive disease - Session Highlights
Tuesday, 18 August 2009
RIO DE JANEIRO, BRAZIL (UroToday.com) - Transurethral resection alone can be effective in muscle invasive tumors.
Login to read more...
|
Maratona Urológica 2009 - Management of non-invasive bladder cancer in the elderly - Session Highlights
Tuesday, 18 August 2009
RIO DE JANEIRO, BRAZIL (UroToday.com) - Bacillus Calmette-Guérin (BCG) is the gold standard for carcinoma in situ (CIS) and high-grade papillary tumors.
Login to read more...
|
Maratona Urológica 2009 - Radiotherapy for bladder cancer - Session Highlights
Tuesday, 18 August 2009
RIO DE JANEIRO, BRAZIL (UroToday.com) - Tri-modality therapy of TURBT, radiation therapy, and chemotherapy is effective therapy for muscle invasive bladder cancer.
Login to read more...
|
Maratona Urológica 2009 - Bladder cancer in the elderly - Session Highlights
Tuesday, 18 August 2009
RIO DE JANEIRO, BRAZIL (UroToday.com) - A recent study from Vanderbilt University detailed the outcomes of 382 patients undergoing radical cystectomy of whom 44 were 75 years of age or older.
Login to read more...
|
Maratona Urológica 2009 - Treatment of muscle invasive bladder cancer in elderly - Slide Presentation
Tuesday, 18 August 2009
RIO DE JANEIRO, BRAZIL (UroToday.com) - Presented by David P. Wood, MD at the VI Maratona Urológica do Rio de Janeiro - August 14 - 15, 2009.
Login to read more...
|
Maratona Urológica 2009 - Radical cystectomy technique and results - Slide Presentation
Tuesday, 18 August 2009
RIO DE JANEIRO, BRAZIL (UroToday.com) - Presented by David P. Wood, MD at the VI Maratona Urológica do Rio de Janeiro - August 14 - 15, 2009.
Login to read more...
|
Maratona Urológica 2009 - Early cystectomy for T1 bladder cancer - Slide Presentation
Tuesday, 18 August 2009
RIO DE JANEIRO, BRAZIL (UroToday.com) - Presented by David P. Wood, MD at the VI Maratona Urológica do Rio de Janeiro - August 14 - 15, 2009.
Login to read more...
|
Maratona Urológica 2009 - Pathology of Bladder Cancer - Session Highlights
Tuesday, 18 August 2009
RIO DE JANEIRO, BRAZIL (UroToday.com) - Currently recommended classification of urothelial cancer is based on the WHO 2004 consensus conference.
Login to read more...
|
Intravesical Bacille Calmette-Guérin therapy for non-muscle-invasive bladder cancer: Effects of concurrent statin therapy - Abstract
Tuesday, 18 August 2009
Division of Urologic Surgery, Department of Surgery, Washington University School of Medicine and Barnes Jewish Hospital, St Louis, MO 63110, USA.
read more
|
Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer - Abstract
Tuesday, 18 August 2009
Department of Epidemiology, University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.
read more
|
Maratona Urológica 2009 - What is the best method to evaluate invasive bladder cancer? - Session Highlights
Tuesday, 18 August 2009
RIO DE JANEIRO, BRAZIL (UroToday.com) - The optimal method of evaluating bladder cancer is with MRI rather than CT due to the intrinsically higher contrast to noise ratio and multiplaner imaging.
Login to read more...
|
Partial cystectomy does not undermine cancer control in appropriately selected patients with urothelial carcinoma of the bladder: A population-based matched analysist - Abstract
Monday, 17 August 2009
Department of Urology, Vita-Salute San Raffaele, Milan, Italy; Cancer Prognostics and Health Outcomes Unit, University of Montreal, Montreal, Quebec, Canada.
read more
|
Urologic oncologist Kellogg Parsons, MD, recognized as health leader
Friday, 14 August 2009
SAN DIEGO, CA, USA (News Release) - August 13, 2009
read more
|
Beyond the Abstract - Multiple adverse histological features increase the odds of under staging T1 bladder cancer, by Alon Z. Weizer, MD
Thursday, 13 August 2009
BERKELEY, CA (UroToday.com) - Patients with T1 bladder cancer have an uncertain natural history.
Login to read more...
|
Intravesical combination treatment with antisense oligonucleotides targeting heat shock protein-27 and HTI-286 as a novel strategy for high-grade bladder cancer - Abstract
Wednesday, 12 August 2009
The Prostate Centre at Vancouver General Hospital and Departments of Urologic Sciences and Earth and Ocean Sciences, University of British Columbia, Vancouver, British Columbia, Canada.
read more
|
Cell adhesion to fibronectin induces mitomycin C resistance in bladder cancer cells - Abstract
Tuesday, 11 August 2009
Department of Urology, Rui Jin Hospital, Shanghai Jiao Tong University School of Medicine, and Department of Histology & Embryology, Shanghai Jiao Tong University School of Medicine, Shanghai, China
read more
|
Oxidative stress sensitizes bladder cancer cells to TRAIL mediated apoptosis by down-regulating anti-apoptotic proteins - Abstract
Tuesday, 11 August 2009
Department of Microbiology and Immunology, Medical University of South Carolina, Charleston, South Carolina
read more
|
Generation of a concise gene panel for outcome prediction in urinary bladder cancer - Abstract
Friday, 07 August 2009
Departments of Pathology, Preventive Medicine, and Urology, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles.
read more
|
A multidisciplinary approach to the management of urologic malignancies: Does it influence diagnostic and treatment decisions? - Abstract
Thursday, 06 August 2009
Division of Urologic Surgery, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
read more
|
Expression and clinical significance of nuclear matrix protein 22 and cytokeratin 18 in transitional cell carcinoma of the bladder - Abstract
Thursday, 06 August 2009
Department of Urology, Shanxi Cancer Hospital, Taiyuan 030013, China.
read more
|
Bladder Cancer 
